Publisher: Global Insight Services
Category: Drug Discovery

Drug Discovery market research reports by Global Insight Services

(95 reports matching your criteria)
    • Parkinson's Disease - Drug Pipeline Landscape, 2024

      Parkinson's Disease - Drug Pipeline Landscape, 2024 Parkinson's Disease (PD) simply called as Parkinson's, is a progressive neuro-degenerative disorder which mainly affects the motor systems due to the depletion in dopamine. The motor symptoms result from the death of cells in the substantia nigra ... Read More

    • Proteomics Market Analysis And Forecast To 2032: By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, and Others), Application (Diagnostic, Drug Discovery, and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, and Other), And Region

      Proteomics Market Analysis And Forecast To 2032: By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, and Others), Application (Diagnostic, Drug Discovery, and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, ... Read More

    • Multiple Sclerosis - Drug Pipeline Landscape, 2023

      Multiple Sclerosis (MS) is an autoimmune disorder in which the immune system attacks the myelin sheath that surrounds and protects the nerve fibers, causing inflammation eventually affecting the brain, spinal cord and optic nerves which disrupts the flow of information within the brain, and between ... Read More

    • Gaucher’s Disease - Drug Pipeline Landscape, 2023

      Gaucher's disease, or Gaucher disease (GD), is an inherited genetic disorder of the lysosomal storage that is caused by a genetic defect of the lysosomal enzyme "glucocerebrosidase." This enzyme accumulates in cells and certain organs, including the spleen and liver. The condition is mainly of 3 typ ... Read More

    • Attention Deficit Hyperactivity Disorder (ADHD) - Drug Pipeline Landscape, 2023

      Attention Deficit Hyperactivity Disorder (ADHD) is a mental health condition that can cause unusual levels of hyperactivity and impulsive behaviours. People with ADHD may also have trouble focusing their attention on a single task or sitting still for long periods of time. Attention deficit hyperact ... Read More

    • Chemotherapy Induced Neutropenia (CIN) - Drug Pipeline Landscape, 2023

      Chemotherapy Induced Neutropenia is a very common side effect of cancer treatment in which the number of neutrophils in the blood drops below a healthy level. Chemotherapy Induced Neutropenia main causes are age, co-morbidities, and time course of therapy. Chemotherapy Induced Neutropenia main sympt ... Read More

    • Biopreservation Market Analysis And Forecast To 2032: By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Providers Volume (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, Others), And Region

      The global Biopreservation Market was valued at USD 2.2 Billion in 2022 and it is anticipated to grow up to USD 26.7 Billion by 2032, at a CAGR of 28.5% during the forecast period. Bio-preservative is a technique for preserving cells, organs, and tissues outside the natural environment to extend she ... Read More

    • Paroxysmal Nocturnal Hemoglobinuria (PNH) - Drug Pipeline Landscape, 2023

      Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare disease in which red blood cells break down earlier than normal. Paroxysmal Nocturnal Hemoglobinuria main causes are age, obesity and hormone therapy, and a genetic disorder. Paroxysmal Nocturnal Hemoglobinuria symptoms includes abdominal pain, bac ... Read More

    • Virus-Like Particles (VLP’s) Market Analysis And Forecast To 2032: By Product Type (Hepatitis, Cancer/HPV, Gaucher Disease), Source (Yeast, Insect Cell, Plant, Others), Application (Vaccine, Therapeutics), And Region

      The global Virus-Like Particles (VLP’s) Market was valued at USD 4.6 Billion in 2022 and it is anticipated to grow up to USD 8.9 Billion by 2032, at a CAGR of 6.8% during the forecast period. Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of auth ... Read More

    • Gastroesophageal Reflux Disease (GERD) - Drug Pipeline Landscape, 2023

      Gastroesophageal Reflux Disease (GERD) or acid reflux is a condition in which the content of the stomach regurgitates (backs up, or refluxes) into the esophagus. The refluxate is usually acidic and can cause inflammation and erosions. Gastroesophageal reflux disease can cause due to frequent acid re ... Read More

    • Social Anxiety Disorder (SAD) - Drug Pipeline Landscape, 2023

      Social Anxiety Disorder is a significant and persistent fear of social and performance-related situations it is one of the most common mental disorders. Social Anxiety Disorder is caused by the complex interaction of biological and environmental factors like inherited traits, brain structure (amygda ... Read More

    • Mucopolysaccharidosis - Drug Pipeline Landscape, 2023

      Mucopolysaccharidosis is a group of metabolic inherited lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, a lysosomal enzyme normally required for the breakdown of certain complex carbohydrates known as glycosaminoglycans (GAGs). There are seven types of mucopolysaccharidosis ... Read More

    • Primary Biliary Cirrhosis - Drug Pipeline Landscape, 2023

      Primary Biliary Cirrhosis - Drug Pipeline Landscape, 2023 Primary Biliary Cirrhosis (Primary Biliary Cholangitis) is a chronic disease in which the small bile ducts in the liver become injured and inflamed and are destroyed eventually. Researcher experts consider it as an autoimmune disease in which ... Read More

    • Diabetic Foot Ulcer - Drug Pipeline Landscape, 2023

      Diabetic Foot Ulcer - Drug Pipeline Landscape, 2023 A diabetic foot ulcer is an open sore or wound that occurs in patients with diabetes and is commonly located on the bottom of the foot. It is one of the health complications caused due to uncontrolled diabetes, people with diabetes may also suffer ... Read More

    • Onychomycosis - Drug Pipeline Landscape, 2023

      Onychomycosis - Drug Pipeline Landscape, 2023 Onychomycosis is a fungal infection of the nail plate, nail bed, or both. Infection may be distal subungual, with nail thickening and yellowing and accumulation of keratin and debris underneath the nail, proximal subungual or white superficial with sprea ... Read More

    • Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2023

      Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2023 Major Depressive Disorder (MDD) also known as clinical depression, is a severe mood disorder which causes persistent or extended periods of depressed or low mood, for more than 2 weeks and a loss of interest in activities thus affecting ... Read More

    • Diabetic Gastroparesis - Drug Pipeline Landscape, 2023

      Diabetic Gastroparesis - Drug Pipeline Landscape, 2023 Diabetic Gastroparesis is a serious complication of diabetes resulting in delayed gastric emptying with associated upper gastrointestinal (GI) symptoms in the absence of any mechanical obstruction. Gastroparesis is a digestive disorder with a hi ... Read More

    • Uveitis - Drug Pipeline Landscape, 2023

      Uveitis - Drug Pipeline Landscape, 2023 Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based on which part of the uvea is affected they are anterior uveitis, inter ... Read More

    • Migraine - Drug Pipeline Landscape, 2023

      Migraine - Drug Pipeline Landscape, 2023 Migraine is a neurological disorder that is associated with recurrent headaches. The headache is characterized by affecting one side of the head, pulsating, moderate to severe in intensity which last for few hours to three days. The underlying cause of migrai ... Read More

    • Systemic Lupus Erythematosus - Drug Pipeline Landscape, 2023

      Systemic Lupus Erythematosus - Drug Pipeline Landscape, 2023 Systemic lupus erythematosus (SLE) also referred as lupus. It is a chronic, inflammatory autoimmune disease with multiorgan involvement. In this condition, the body attacks its own immune system and causes inflammation as well as tissue da ... Read More

    • Angina Pectoris - Drug Pipeline Landscape, 2023

      Angina Pectoris - Drug Pipeline Landscape, 2023 Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. A ... Read More

    • Acromegaly - Drug Pipeline Landscape, 2023

      Acromegaly - Drug Pipeline Landscape, 2023 Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights. T ... Read More

    • Hepatitis D (HDV) - Drug Pipeline Landscape, 2023

      Hepatitis D (HDV) - Drug Pipeline Landscape, 2023 Hepatitis D, also known as delta hepatitis, is an inflammation of the liver caused by the hepatitis D virus (HDV), which requires HBV for its replication. Hepatitis D infection cannot occur in the absence of hepatitis B virus. HDV-HBV co-infection is ... Read More

    • Graft Versus Host Disease (GVHD) - Drug Pipeline Landscape, 2023

      Graft Versus Host Disease (GVHD) - Drug Pipeline Landscape, 2023 Graft Versus Host disease (GVHD) is an immune mediated systemic disorder associated with complex interaction between donor and recipient adaptive immunity. It is a common complication after hematopoietic stem cell transplant (HCT), her ... Read More

    • Hyperparathyroidism - Drug Pipeline Landscape, 2023

      Hyperparathyroidism - Drug Pipeline Landscape, 2023 Hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone, an 84-amino acid polypeptide hormone. The secretion of parathyroid hormone is regulated directly by the plasma concentration of ionized calcium. Primary h ... Read More

< prev 1 2 3 4

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings